Canine infection test redesigned to create less laboratory wastage
Canine infection test redesigned to create less laboratory wastage
A new smaller veterinary test kit for the diagnosis of viral and bacterial infections in dogs has been unveiled by global diagnostics company Randox Laboratories.
Suitable for the testing of a wide range of breeds, the test, which monitors levels of C-Reactive Protein (CRP) produced by the liver in response to inflammation, infection and tissue injury, has been redesigned in a smaller size to reduce consumable wastage.
Randox Canine CRP can diagnose conditions such as pancreatitis (inflammation of the pancreas), cystitis (a bladder infection) and inflammatory bowel disease, and can also be used to establish if a dog is pregnant.
Lynsey Adams, Randox Clinical Marketing Manager, commented;
“The redesign of our Canine CRP kit size, which has reduced the volume of the CRP reagent for the diagnosis of canine infection, means that laboratories will produce less waste, and ultimately, be more cost-effective.
“The wide measuring range of this test allows for slight variations of normal ranges across different canine species and ensures accurate results for all breeds.”
Concentration levels of CRP elevate in the blood of canines much earlier post-injury or infection than other biomarkers. This rapid response following trauma (usually within 4 to 6 hours), as well as the fact that CRP levels return to normal quickly at the end of an acute episode, make Canine CRP useful for both the detection of acute inflammation episodes and the monitoring of its treatment, such as steroids or antibiotics.
“As in humans, CRP is used as a marker of inflammatory activity, but with the Randox Canine CRP test, which uses the same high-quality materials as our human assay, CRP can also be tested in dogs to establish a range of viral and bacterial infections.
“As CRP in healthy dogs is present in low concentrations (5 mg/dl), but can elevate to 600 mg/dl, testing for this biomarker can not only detect inflammation but also provide information on its severity.”
The new test from Randox enhances an already comprehensive veterinary test menu of high performance and superior animal health assays including Bile Acids, D-3 Hydroxybutyrate (Ranbut), Glutathione Peroxidase (Ransel) and Total Antioxidant Status, for agriculture and livestock, companion animals, university and research institutes, and the sports industry.
Randox veterinary solutions also include quality control, external quality assessment (EQA) and the RX series range of clinical chemistry analysers.
“We have over 30 years’ experience as a supplier to the veterinary market and are proud to be able to offer veterinarians and other professionals in the animal health industry, tests which are of the highest quality, accuracy and efficiency.
“Offering the complete veterinary diagnostics package of clinical chemistry analysers, reagents, and quality control, Randox is transforming the landscape of veterinary diagnostics, by providing a time and cost effective, flexible and versatile approach to animal health testing.”
Benefits of the new Randox Canine CRP Kit
- Immunoturbidimetric method.
- New kit size – R1 2 x 18.1ml, R2 2 x 5ml offering efficiencies in cost and reagent wastage.
- Wide measuring range of 0.8 – 220mg/dl for the comfortable detection of clinically important results. CRP in healthy dogs can be found at levels below 35 mg/L, therefore Randox Canine CRP comfortably detects abnormal levels.
- In addition, a wide measuring range allows for slight variations of normal ranges across different canine species and ensures accurate results for all.
- Liquid ready-to-use reagents for convenience and ease of use.
- Calibrator included in the kit offering a cost effective canine CRP testing solution.
- Dedicated canine CRP controls available offering a complete testing package.
- Instrument specific applications available for a wide range of clinical chemistry instruments.
Want to know more about Randox?
Contact us or visit our homepage to view more.
Our Randox Products and Services
For our 2018/19 placement students, their year with Randox is almost at an end.
To mark their time with us and wish them the best of luck with their future studies, we took the opportunity to speak with one of our placement students in the sales team, to give us an insight of her experience during a Randox placement year.
Meet Kathryn Wilson, Business Placement Sales Executive for Randox Biosciences.
Hi Kathryn, can you tell us a little bit about yourself?
I am a 21-year-old student studying Bsc Equine and Veterinary Bioscience at Aberystwyth University in Wales. In September 2018 I began working in the Biosciences division of Randox Laboratories, specifically working on the release of new molecular technologies for clinical diagnostics. As part of a newly formed sales team, my focus is on the diagnostics market in Ireland.
Why did you want to forge a career in sales?
Whilst studying my bio-veterinary degree my only focus had been on science, so I was keen to broaden my horizons and explore opportunities in a business role for a company involved in the life-sciences industry. Initially, I was tentative of a role in sales, but I knew it would be a good way to develop a broad knowledge of business and the industry, and develop new skills.
Why did you decide to take your placement year with Randox?
Randox was a perfect fit for me, as a global scientific company based in Northern Ireland. I was looking for a placement that would allow me to spend time at home before returning to Wales for university.
I was intrigued by their range of products and diverse market presence in industries such as pharmaceuticals, biotech, research and healthcare. It seemed like a good company to gain an insight into new research in a variety of career sectors.
Describe a typical day as a Business Placement Sales Executive.
My role has evolved as we have moved through the different stages of product development throughout the year. Initially, when I first joined the team, we were in the planning stage. This involved mapping potential contacts and key sites in Ireland, and developing a sales strategy.
As this is a new venture for Randox the role also involved educating the market on our technology and creating awareness in all potential points of sale. This educational aspect of my job involved regular trips and meetings across Ireland, and frequent UK team meetings to discuss market feedback and problem solve. It’s important that we have been able to adapt our sales strategy for the specific healthcare areas -from public to private and point-of-care to large laboratories. Coming into the final month of my placement we are now prepared for product release with confirmed validation studies and initial placements, and significant interest across Ireland.
What are some examples of the tasks and responsibilities of your role?
There has been a range of ongoing tasks throughout the year to facilitate a busy and growing division. I was given the responsibility of forecasting, logging orders and organising meetings, and have been involved in internal decision-making processes alongside management. I have also helped to manage the university contracts in Ireland for our lab equipment, reagents and outsourcing some testing for specific studies.
Before I finish my placement I’m researching the market for upcoming arrays for launch next year, and planning a final trip in Ireland.
What was the most exciting part of your placement with Randox Biosciences?
The opportunity to travel around Ireland and London has been excellent. To date I have participated in over 10 conferences on behalf of Randox. Highlights for me have been corporate hospitality with potential customers at the Randox Health Grand National, and presenting at the first Infectious Disease Forum for Randox, in front of representatives from microbiology sites across Ireland.
I was also trusted to conduct a trip on my own around Donegal and Sligo, coupled with a visit to our Donegal R&D site, Randox Teoranta in Dungloe, to learn about future veterinary arrays in development.
It has been a privilege to be able to work with such a diverse range of people – from the scientists developing the products, to the sales team specialising in markets across the globe. There are so many different career paths here at Randox.
What has been the most challenging aspect of your time at Randox Biosciences?
I have been challenged to quickly adapt to the business environment and gain an in-depth understanding of the wide range of products. I have been pushed outside my comfort zone to discuss with customers, present to the team and take responsibility of the day-to-day tasks.
Knowing the new molecular diagnostics range, infectious disease panels, and competitors in the market well enough to be confident in front of potential customers on my own, has also been a challenge. Hard work at Randox is acknowledged however, and I was awarded runner-up Business Student of the Year.
What is the best thing about Randox and would you recommend this placement to other students?
The best thing about a placement with Randox is that you will be given as many opportunities as you are willing to take. They are very supportive and will push you as much as any other member of the team.
As a non-business student this year has given me a wealth of insight into the workings of a global company, as well as furthering my scientific knowledge and interests in many aspects of the industry.
I would recommend a Randox placement for students who are keen to gain as much experience as possible in a global company focused on new and exciting health research.
What are your goals for the future?
My experience at Randox has given me an excellent insight into the world of business in the biosciences industry, and has prepared me well to build a career in this exciting industry. I think that the experience gained through Randox will be applicable to many life sciences sectors which I would like to explore further.
Although I am not sure what the future may hold, in the shorter term I am looking forward to returning to finish my final year at Aberystwyth.
For more information about Randox Biosciences and what career opportunities we offer please contact email@example.com
Pet Food companies worldwide are working towards constantly improving and maximising the quality of their product. The problematic topic of mycotoxin contamination in pet feed is quickly becoming a major cause for concern. This is due to the risk they pose for animal health and with the increasing prevalence of mycotoxins globally the focus is on pet food companies to meet EU and FDA regulations and maximise the quality of their product.
What are Mycotoxins?
Mycotoxins are naturally occurring metabolites that are produced by certain moulds and with the ability to develop and grow on a variety of crops they can affect large amounts of feed and increasingly, pet food. If a sample tests positive even for low levels of contamination the toxins are still strong enough to cause illness in animals, and if low levels are consumed over a long period of time this can result in chronic illnesses including; cancer, organ damage and neurological disorders.
The main mycotoxins of concern in pet food are;
- Deoxynivalenol (DON)
- Fumonisins (FUM)
- Zearalenone (ZEN)
- T-2 Toxin
Contamination can occur in any country around the world and at any stage of production. Herein lies the issue of how to prevent mycotoxin pollution, to tackle the issue head on and work towards a mycotoxin free product is the joint responsibility of feed producers, supply chain partners and quality control laboratories ensuring the complete safety of the product.
How can you tell if an animal has ingested pet food contaminated with mycotoxins?
In terms of animal health, mycotoxins can cause a variety of problems. Severity and symptoms can vary from animal to animal but general symptoms include; hyperactivity, vomiting, high temperature and loss of coordination. If you suspect your pet has been affected by mycotoxins you must bring them to the vet for immediate treatment.
The European Union currently regulate all the mycotoxins listed above and are subject to maximum or recommended residue limits. In the US, FDA regulations are limited to aflatoxins, DON and fumonisins, see table below for FDA regulations. If mycotoxin levels in feed fail to meet FDA standards, mass amounts of feed may need to be destroyed as grain producers are prohibited from mixing contaminated feed with clean feed to reduce the mycotoxin levels.
|Immature Animals||Aflatoxins||Corn/ peanut/ other ingredients||20 ppb|
|Adult Pets||Aflatoxins||Corn/ peanut/ cottonseed meal/ other ingredients||20 ppb|
|DON||Grain/ grain byproducts, not to exceed 40% of diet||5 ppm|
|Fumonisins||Corn/ corn byproducts, not to exceed 50% of the diet||10 ppm|
How do we tackle the problem?
Safe, reliable screening solutions for different variations of mycotoxins are available that can ensure only mycotoxin free feed is produced. Randox Food Diagnostics have created mycotoxin screening platforms as a response to increased levels of mycotoxins being found in feed globally.
The platforms use patented Biochip Array Technology (BAT) so pet food producers can test for multiple toxins from a single sample. Randox Food Diagnostics have a range of mycotoxin Biochip Arrays available with customised arrays available to suit the specific screening needs of certain producers. Each Biochip format uses a straightforward extraction process with a 50µl sample of feed, available tests include; Fumonisins, Ochratoxin A, Aflatoxin G1/G2, Aflatoxin B1, Paxiline, Ergot Alkaloids, Diacetoxyscirpenol, Deoxynivalenol, T2 Toxin and Zearalenone.
For more information on mycotoxin screening with Randox Food Diagnostics contact firstname.lastname@example.org
Liverpool’s reputation as one of the world’s greatest sporting cities is being pushed to the fore by an exciting collaboration between the new Grand National sponsors Randox Health, the prestigious Liverpool John Moore University (LJMU)’s School of Sports and Exercise Science, and the University of Liverpool’s Philip Leverhulme Equine Hospital.
The event, known as Randox Health Week, is free and open to the public between Monday 3rd and Wednesday 5th April – the three days prior to the Randox Health Grand National.
Teaming up with a racing legend, Olympic athlete and boxing champion, three days of interactive sporting programmes will teach hundreds of local students about the importance of harnessing their health in order to achieve sporting excellence.
During each morning session of Randox Health Week, pupils and their teachers from across Merseyside and Cheshire, with the help of qualified coaches and sport scientists, will be put through professional fitness programmes, including combat sports such as boxing and taekwondo, and high interval training such as indoor cycling. During these exercises, which will include the opportunity to experience life as a jockey by having a go on a horse simulator, the children will also have some physiological measurements taken, including their heart rate.
The event will be given an added touch of excitement in the form of attendance by Liverpool’s renowned jockey Franny Norton and the city’s boxing champion Derry Mathews, as well as Olympic Sailor Matt McGovern.
In the afternoon sessions, guests can then participate in presentations given by world-leading authorities on the benefits of a preventive health approach in exercise and life in general. A highlight from Monday’s afternoon session will be Dr George Wilson discussing the effects of weight-making strategies on jockeys and how to move beyond negative practices. He will be joined by The Stroke Association who further back advocating a preventive health approach.
The afternoon of Tuesday 4th April will provide a unique insight into horse health, and specialist equine vets from the University of Liverpool’s Philip Leverhulme Equine Hospital will join the sports scientists at Liverpool John Moores University to provide the equine health perspective. Professor Cathy McGowan, who will investigate equine excellence in racing and the increasing use of blood tests in training horses, will be joined by Harry Carslake, discussing why clean air and lungs are crucial for performance, and representatives from equine feed specialists Dodson & Horrell.
Professor Cathy McGowan, Head of Department of Equine Clinical Science and Director of Veterinary Postgraduate Education at the University of Liverpool’s Equine Hospital, commented;
“The racehorse is one of the finest athletes on the planet with a highly specialised physiology to enable it to perform at such high levels. We will be focussing on highlighting that unique physiology and also how understanding that is used to monitor and maximise the health of these equine athletes.
“We are delighted to be involved with Randox Health in providing these educational seminars at LJMU as well as at the Aintree Grand National on Friday and proud to be supporting Randox’s involvement in equine and human health.”
Wednesday afternoon of Randox Health Week will feature a topic that can lead to devastating consequences – the impacts of training on artery health and early detection of cardiovascular disease in humans.
Dr Peter FitzGerald, CEO of Randox said:
“We are delighted to be teaming up with Liverpool John Moores University as part of Randox Health Week ahead of the Randox Health Grand National. With over 34 years’ experience in the diagnostics industry we have developed innovative and accurate technology for use in humans that reveals our current and future health. Our equine panel is able to assess the impact of training on endurance racehorses to increase their performance and well-being. The Grand National offers us the perfect platform to spread our message of preventive health for people and horses, and we look forward to sharing our knowledge with the audiences at this exciting event.”
Professor David Richardson, Director of the LJMU School of Sport and Exercise Sciences commented:
“The School of Sport and Exercise Sciences is delighted to be working with Randox. Our research has already had a major impact on the health and wellbeing of jockeys and reduced the occupational risk of race riding not only in the UK but throughout the world. The workshops are intended to raise the students’ understanding of these appropriate training protocols and techniques associated to horse riding and different sports at an elite level and the aligned health benefits.”
There will also be a tour of the Research Institute for Sport and Exercise Sciences (RISES), the top ranked institution in the UK for research in sport and exercise sciences* where many elite athletes benefit from world-leading research.
To register please visit:
Or for further information click:
Filming/photo and interview opportunities
- Date: Mon 3rd, Tues 4th and Wed 5th April prior to the Randox Health Grand National Festival, starting on 6th
- Each workshop will last for approximately 40mins and will involve active participation
- Venue: Liverpool John Moores University, James Parsons Lower Lecture Theatre and Tom Reilly Building, Byrom Street, Liverpool, L3 3AF
- Time: 0900 – 1200
For more information about Randox Health Week please contact Randox PR on 028 9442 2413 or email RandoxPR@randox.com
Since the opening of Randox Teoranta back in 2010, our team of scientists, engineers and software developers has grown significantly.
Career opportunities at our state-of-the-art research, development and manufacturing centre is utilising the talented skill set of Donegal people and newcomers alike, while actively attracing the Donegal Diaspora back to the area.
Donegal graduates who are working away from home have the opportunity to return, or for those from further afield, they have the opportunity to experience the distinct Donegal lifestyle for the first time.
Senior R&D Scientist at Randox Teoranta in Dungloe, Dr Sarah Gildea, returned to her native Donegal to work in Randox Teoranta, after having worked in the Irish Equine Centre in Kildare. She chatted to us about her PhD in Equine Influenza Virus and what she loves the most about being home.
Hi Sarah, can you tell us a little bit about your background and where you started your career?
I’m originally from Ardara which is in the south west of Donegal and about half an hour away from Dungloe where Randox Teoranta is based. Once I graduated from the University of Limerick with a Bsc in Equine Science, I got a job in the Virology Unit of The Irish Equine Centre, which is in Kildare. I stayed there for 13 years and during that time I got the opportunity to complete my PhD in Equine Influenza Virus.
Why did you choose Randox Teoranta?
After travelling to Kildare each week I finally got the opportunity to return home to work last June when I was lucky enough to join the Randox Teoranta team here in Dungloe. Travelling to Kildare was beginning to take its toll on me – I wasn’t home until late Friday evening and then I was away again on Sunday so it was always a short trip home. Don’t get me wrong now, it’s great to travel and see different parts of the world that you wouldn’t get the opportunity to see otherwise, but being a bit of a home bird I had wanted to come home for a while. I never thought that I would get the opportunity to work at home in the field of science, especially veterinary science. So as you can imagine I was delighted when I heard that Randox was opening a new R&D site in Dungloe and was expanding their expertise to include a veterinary division. I thought it was such a rare opportunity to be given the chance to work in my area of expertise so close to where I grew up.
What’s the difference in terms of the facilities between Randox Teoranta and the Irish Equine Centre?
Coming from the Irish Equine Centre where I was involved in diagnosing diseases for race horse trainers and veteran surgeons from all around Ireland to Randox Teoranta where I am developing tests to supply the likes of Irish Equine Centre and like-minded companies had its advantages. I already had a broad knowledge of vet diagnostics and diseases but now instead of diagnosing diseases I am creating the innovative diagnostic tests that the Irish Equine Centre would use. It meant that I already had a good knowledge on the flaws of some of the current tests and my experience gave me a good insight for what’s important when developing new innovative diagnostic tests.
How important is it that companies like Randox invest in places like Dungloe?
By investing in science and engineering at Randox Teoranta I have not only been able to bring back my knowledge and experience to my home county, but also teach and educate those in the community who are interested in pursuing a career in science but don’t necessarily want to travel far from home. Randox Teoranta not only allows me to give back to the community but also make huge savings on travel expenses as I no longer have to commute long distances to work each day. But really the most important thing for me is being close to all my family and friends.
For more information about our Randox Teoranta Open Morning on Friday 23rd December please contact email@example.com
Make sure to share on your social media platforms using the hashtag #TalentedTeoranta!
We wouldn’t be the experts in Equine Health we are without our team of highly knowledgeable and experienced veterinary scientists.
Dr. Sarah Gildea, Senior R&D Scientist at Randox Teoranta in Dungloe, Co. Donegal, Ireland, has a BSc Equine Health, a PhD in Equine Influenza Virus, and spent many years working in the Virology Unit of The Irish Equine Centre prior to joining our team.
‘Randox Diagnostics: Leading the Field in Equine Health’
by Dr. Sarah Gildea BSc PhD, Senior R&D Scientist at Randox
“With over 30 years’ experience, Randox is a leading specialist in the development of veterinary diagnostic solutions. Our extensive product portfolio includes diagnostic reagents, quality controls, external quality assessment (RIQAS) and the Rx series of clinical chemistry analysers which are specifically designed to monitor the general health and well-being of a diverse range of animal species.
“Long established in the equine market, our clinical chemistry analysers provide the largest and most comprehensive test menu available and are used extensively to monitor the health and nutritional status of horses all around the world. In addition, our clinical chemistry tests can also be used for therapeutic drug monitoring, assessing reproductive fitness and as an indirect method in the diagnosis of certain equine diseases/conditions.
“Equine infectious anaemia (EIA) otherwise known as “swamp fever” is a viral disease affecting horses which can cause intermittent fever, anaemia, emaciation and eventual death. Although the disease is not always fatal, infected horses can become disease carriers thus posing a significant risk to other equines. Hence, rapid diagnosis is of fundamental importance. In a study carried out in Romania where the virus is endemic, a novel link between oxidative stress (measuring Total Antioxidant Status, Superoxide Dismutase and Glutathione Peroxidase) and EIA viral infection was established (Bolfă PF et al., 2012). The assessment of oxidative-antioxidative status in blood has also been investigated for a variety of other equine diseases and a correlation between oxidant-antioxidant imbalance and exercised induced pulmonary haemorrhage (Mills and Higgins, 1997), equine motor neuron disease (Delguste et al., 2007), recurrent airway obstruction (Deaton et al., 2006), joint disease (Dimock et al., 2000), endometritis and colic (Krumrych et al., 2013) has been identified. Such findings highlight the broader use of clinical chemistry tests in studying the pathogenesis and pathomechanisms of equine diseases.
“The increased participation of equine athletes in different sports and disciplines has resulted in a rise in the incidence of joint problems, with osteoarthritis now a common finding among performance horses. Similar to all athletes, the equine appendicular skeleton is under extreme pressure when participating in any intense physical training or equestrian events. Although some horses may remain clinically unremarkable, such physical exertion can result in various inflammatory disorders with subsequent increased risk of injury. Analysis of total protein in joint synovial fluid using the Randox Rx series of clinical chemistry analysers plays an important role in the study of equine orthopaedics worldwide and in the identification of appropriate therapeutic tools to enhance healing. The measurement of other well established biomarkers e.g. Total Antioxidant Status, Superoxide Dismutase, Serum Amyloid A and Creatine Kinase in monitoring response to exercise, transport, trauma and stress have all been previously reported using Randox technology and the results well documented in the scientific literature.
“In addition, using our clinical chemistry analysers, the measurement of seminal plasma antioxidant activity has been demonstrated as a useful indicator of semen quality and subsequent reproductive capability in performance stallions. In a study carried out by Härtlová et al., (2013) stallions experiencing induced sport workload stress were found to have higher levels of aspartate aminotransferase (AST) and alanine aminotransferase (ALT) compared to those without workload stress. A correlation between an increased level of these intracellular enzymes in seminal plasma and defects in the spermatozoa membrane has previously been established (Katila, 2001).
“Randox is also actively involved in the development of tests for the detection of performance enhancing substances in horses. Such testing protects the safety and welfare of these animals and ensures that competitions are won primarily on merit. This testing is performed not only using our innovative Biochip Array Technology but also our Rx series of clinically chemistry analysers. During prolonged strenuous exercise, racehorses can experience acidemia. In an effort to enhance racing performance “bicarbonate loading” by trainers was first identified in the early 1990s and since then some racing authorities have identified a limit of total carbon dioxide (TC02) concentration which is permissible in horses prior to competition. A comparative study carried out in Australia which examined the capability of four clinical chemistry analysers (Beckman Synchron EL-ISE®, Beckman Synchron CX®5, Beckman UniCel DxC®600, Randox DaytonaTM) to measure TC02 in equine plasma reported that the Randox Daytona offered a high degree of accuracy and precision when compared to the gold standard. Of important logistical consideration however, this study identified the Randox Daytona as the only instrument sufficiently “portable” to allow TC02 testing to be carried out not only in a laboratory but also “onsite” at a racetrack in a laboratory vehicle (Jarrett et al., 2010).
“So as you can see – for all your equine needs from general health screening, monitoring response to exercise or injury, identifying suitable therapeutics and their appropriate threshold, studying the pathogenesis and pathomechanisms of certain equine diseases and assessing reproductive fitness – the Randox Rx series offers it all.”
For more information about our work in the area of Equine Health, please contact firstname.lastname@example.org
Bolfă, PF., et al. (2012) Oxidant-antioxidant imbalance in horses infected with equine infectious anaemia virus . Vet J 2012, 192: 449-454
Deaton, CM., et al (2006) Comparison of the antioxidant status in tracheal and bronchoalveolar epithelial lining fluids in recurrent airway obstruction. Equine Vet J 2006, 38: 417-422
Delguste, C et al., (2007) Change in blood antioxidant status of horses moved from a stable following diagnosis of equine motor neuron disease . Can Vet J 2007, 48: 1165-1167
Dimock, AN., et al (2000) Evidence supporting an increased presence of reactive oxygen species in the diseased equine joint. Equine Vet J 2000, 32: 439-443
Härtlová, H., et al. (2013) Semen quality, lipid peroxidation, and seminal plasma antioxidant status in horses with different intensities of physical exercise. Acta Vet Brno 2013, 82: 031–035
Jarrett, M (2010): Alternative instrumentation for the analysis of total carbon dioxide (TC02) in equine plasma. Anal Bioanal Chem 2010, 397: 717-722
Katila, T (2001): In vitro evaluation of frozen-thawed stallion semen: A review. Acta Vet Scand 2001, 42: 199-217
Krumrych, W., et al. (2013) Oxidant/antioxidant status assessment of blood in selected equine diseases. Bull Vet Inst Pulawy 2013, 57: 225-230
Mills PC and Higgins AJ (1997) Oxidant injury, nitric oxide and pulmonary vascular function: implications for the exercising horse. Vet J 1997, 153: 125-148
Did you know that one of the reasons we entered into partnership with the Jockey Club is because we are experts in the field of Equine Health?
Well now you do!
Not only do we have a history of being involved in equestrian events, (we host the Randox Point-to-Point event for our local community every year, and International Polo Tournaments in both Scotland and Bushmills, on the Causeway Coast of Northern Ireland), but we also have over 34 years’ experience in the diagnostics industry, during which we have developed innovative and accurate diagnostic products for Equine Health.
That may sound complicated but vets, trainers and owners have been working with us for years so that we can help them better understand their horses’ health and wellbeing.
To recognise the importance of what we do, you must know that more than 70% of all medical decisions are based on an analysis of your blood.
Using our innovative blood-science technology we can obtain a comprehensive profile of not only your body’s current health, but also your future health. This is the same for horses!
In the development of our own dedicated Equine Health Programme, we’ve learnt a thing or two. We know that endurance racehorses require extra attention as a result of intense physical exercise, and therefore monitoring what’s going on in their blood is vitally important.
To give an example, monitoring the Total Antioxidant Status of your horse is a sure-fire way to detect whether he or she has suffered muscle cell injury or trauma.
A reduction in the overall antioxidant status of your horse inhibits its body’s defence and monitoring the TAS is therefore an efficient way to identify risk of injury, determine the levels of training required and establish appropriate recovery times to maintain their wellbeing.
If your horse is often transported between locations it’s also important to monitor his or her TAS. The Total Antioxidant Status of a horse may increase after long-haul road transportation, indicating that your horse is stressed.
So, as you can see, you can tell a lot about the health of your horse by looking at what’s going on in their blood. We’re the experts in this area so we can share our knowledge with you, explain the importance of particular biomarkers in observing the health of your horse, and advise you what areas of your horse’s health you should be monitoring if you have particular concerns.
Let’s say for example your horse is undergoing intense training.
We would recommend that you monitor their levels of Superoxide Dismutase. This enzyme can let you know whether they are suffering from any muscle pain, stiffness, joint weakness, loss of muscle strength, stamina and flexibility, amongst other issues. It is important to know whether their current training is regime is benefitting them, or encumbering them.
If injury is suspected, we then advise that you monitor your horse’s levels of Creatine Kinase.
Any damage to your horse’s heart, skeletal muscle or brain tissue will result in a spike of Creatine Kinase in the blood. By monitoring CK, you can determine any muscle trauma, bruising, wasting, abscesses, inflammation, infection and recurring muscle damage.
Laminitis, a painful inflammatory condition of the tissue, is often one of the most concerning conditions for any horse, as historically there has been minimal opportunity to detect the risk or early stages of the disease. Randox Adiponectin, a protein hormone, is now being used in conjunction with other current biomarkers to successfully detect the risk of this disease and allow earlier management of the condition in the aim to remove the risk completely or reduce its life-altering impact.
The importance in monitoring these biomarkers is of course that it enables early treatment, which greatly improves your horse’s prognosis and chances of recovery.
Swift treatment upon diagnosis of trauma ensures that your horse is kept healthy and happy, and our customers agree! We work with a number of key Veterinary Hospitals around the world, including Rood and Riddle Equine Hospital, the Official Equine Hospital of the Breeders’ Cup in Lexington, Kentucky, (known as ‘The Horse Capital of the World!), and The Irish Equine Centre in Kildare, Ireland.
Jean Hearn, Biochemistry Lab Manager at The Irish Equine Centre, commented;
“As a long time customer of Randox Laboratories, over thirty years, I feel I am in a good position to offer an opinion on the company. Initially we dealt with Randox for Chemistry Reagents and ELISA kits, as they offered a very good range for us working in the veterinary field. However when they launched their Randox Daytona, we found it to be an essential additional analyser in our laboratory, due to the fact that it was capable of running tests that prior to that we were running with very labour intensive methods. eg various minerals and it also broadened the range of tests we could offer to our customers ,eg. acute phase proteins.
“Support has always been good from Randox and the staff always very pleasant and helpful.”
Of course what your horse eats plays a huge role in their health too.
High quality horse feed is paramount for race horses in particular whose speed, agility and most importantly, health, is dependent on them receiving all the nutrients they require.
Our Randox Food Diagnostics ensures the safety of horse feed by screening the food for harmful mycotoxins which can grow on a variety of different crops including cereals, grains and fruits, and can cause a number of health issues for horses, including problems with fertility, sports performance and malnutrition.
And our work in the racing industry doesn’t stop there.
Our Randox Toxicology division creates custom testing panels for the screening of drugs of abuse, on our patented Randox Biochip Array Technology, which has revolutionised the diagnostics industry by allowing multiple tests to be run simultaneously on a single, undivided patient sample.
Screening for drug abuse amongst jockeys in this way (we currently work with Jockey Clubs around the world including Sha Tin racecourse in Hong Kong) protects the safety of the horses and ensures races are won on the jockeys’ and the animals’ natural abilities.
Hopefully you now have a flavour for the work that we do in the racing and veterinary industries to ensure the health and wellbeing of horses. We hope that through our sponsorship of the Randox Health Grand National we can share our knowledge and expertise in the field of Equine Health, Horse Feed Screening and Jockey Toxicology with the racing fraternity.
Just as we promote a message of preventive health to racing fans, the same applies to the horses we love.
For further information on how we work to keep horses healthy, please contact our Randox PR Team.
T: 028 9445 1016
We’re sure you’ve heard of “Speed Dating”, but what about “Speed Networking”? Randox’s R&D Scientist, Dr. Dwaine Vance tried it out to spread the word about Randox Careers in STEM!
Dr Dwaine Vance visited Omagh High School to represent Randox Careers. He sat down with us, and we discussed the importance of the event. Dr. Vance told us:
On Wednesday the 15th June I represented Randox Careers at a ‘speed networking’ event at Omagh High School. This involved groups of students moving from one employer stand to the next for a 5 minute ‘mini network’. There was two sessions during the morning involving GCSE level pupils. The aim of the ‘speed networking’ event was to provide pupils with opportunities to meet local Northern Irish companies within the Science, Technology, Engineering and Mathematics (STEM) sectors, of which Randox Laboratories play a pivotal role.
We, at Randox, want to inspire students to think about their own career plans and to allow them to gather information about the local job market. By doing this, we’re also giving them the opportunity to be aware of the jobs that are available and the importance of STEM related subjects, as well as letting them see how employers value their other curriculum subjects and their personal skills and attributes. My objective as a employee of Randox was to showcase a range of careers for all abilities within the company with a focus on STEM careers e.g. science and engineering.
The importance of spreading awareness of the opportunities in science and engineering from a young age is imperative, as many students are unaware of the vast range of differentiation in different careerpaths, stemming from one subject or degree class. Dr. Dwaine Vance went on to discuss the events of the networking conference:
As part of each ‘mini network’ I provided students with a brief overview of Randox. Students were given the opportunity to watch videos depicting our expertise and to ask questions about how their interests could be incorporated within Randox. The training department at Randox provided me with pop-up stands, recruitment pathway brochures, merchandise e.g. pens, stopwatches, mug coasters and even Biochip Array Technology key rings!
Overall the students gained a good knowledge of Randox, they were particularly keen to learn about the local and global opportunities available at Randox. In addition, students were keen to know more about the veterinary aspect of Randox. It was comforting to discover that the majority of pupils had previous knowledge of the Randox brand from the press (as we have recently experienced a great boost in brand visibility through Grand national sponsorship), Randox health (television adverts) and Confidante (local radio stations).
The pupils at Omagh High School were keen to ask me about my role within the company and what my day to day roles and responsibilities are. I was happy to provide students with my research and development activities and they were interested to hear that I was involved in the development of a genetic test that aims to predict your future risk of heart disease by investigating your own DNA.
At Randox I am part of a small team of experienced research scientists that are developing a genetic risk prediction test for heart disease and myocardial infarction. This test aims to simultaneously genotype 20 genetics variants that have been previously associated with increased risk of heart disease. This Randox molecular test is in collaboration with leading University academics and will help reduce the burden of heart disease throughout the world by providing an accurate risk assessment of disease so personalised treatment can be provided to those who require it most. To quote Randox Health, “Prevention is better than cure”.
From everyone at the Randox Careers team and from Dr. Dwaine Vance, we’d like to thank Omagh High School for inviting us to attend this incredibly beneficial Speed Networking event, where we feel we have truly impacted the young minds of tomorrow. We look forward to the future of diagnostics, with you!